<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
	<title>Proactiveinvestors United Kingdom Xenetic Biosciences  items</title>
	<link>http://www.proactiveinvestors.co.uk</link>
	<description>Proactiveinvestors United Kingdom Xenetic Biosciences  items RSS feed
            </description>
	<language>en</language>
	<pubDate>Thu, 24 May 2012 15:04:40 +0100</pubDate>
	<docs>http://blogs.law.harvard.edu/tech/rss</docs>
	<generator>Genera CMS</generator>
	<managingEditor>action@proactiveinvestors.com (Proactiveinvestors)</managingEditor>
	<webMaster>action@proactiveinvestors.com (Proactiveinvestors)</webMaster>
	<atom:link href="http://www.proactiveinvestors.co.uk/LON:XEN/Xenetic-Biosciences/rss/media" rel="self" type="application/rss+xml" />
		<item>
			<title><![CDATA[Xenetic CEO says its focus is about controlling its own future and so create shareholder value ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/stocktube/1022/xenetic-ceo-says-its-focus-is-about-controlling-its-own-future-and-so-create-shareholder-value-1022.html</link>
			<description><![CDATA[Scott Maguire, <a href="http://www.proactiveinvestors.co.uk/companies/overview/949/Xenetic+Biosciences" class="companyPopupTrigger" rel="949">Xenetic Biosciences</a> (<a href="/companies/overview/949/xenetic-biosciences--0949.html" class="companyPopupTrigger" rel="949">LON:XEN</a>) CEO, tells <a href="http://www.proactiveinvestors.co.uk/companies/overview/8792/Proactiveinvestors" class="companyPopupTrigger" rel="8792">Proactiveinvestors</a> that the overall strategy is to "de-risk biotech" and enable it to better control its own future. Scott also says that the money the Xenetic has recently raised means that it's now better funded that it has ever been. ]]></description>
			<pubDate>Fri, 10 Feb 2012 11:05:00 +0000</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/stocktube/1022/xenetic-ceo-says-its-focus-is-about-controlling-its-own-future-and-so-create-shareholder-value-1022.html</guid>
		</item>
		<item>
			<title><![CDATA[Xenetic Biosciences One2One Presentation - 8th November 2011 ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/ceo_focus/928/xenetic-biosciences-one2one-presentation-8th-november-2011-.html</link>
			<description><![CDATA[Xenetic Biosciences One2One Presentation - 8th November 2011 ]]></description>
			<pubDate>Tue, 08 Nov 2011 10:41:00 +0000</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/ceo_focus/928/xenetic-biosciences-one2one-presentation-8th-november-2011-.html</guid>
		</item>
		<item>
			<title><![CDATA[Scott Maguire, CEO of Xenetic Biosciences, talks to Proactive Investors ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/ceo_focus/880/scott-maguire-ceo-of-xenetic-biosciences-talks-to-proactive-investors-880.html</link>
			<description><![CDATA[Scott Maguire, CEO of Xenetic Biosciences, talks about David Cameron announcing this deal, Russia becoming a global biotech player, first such deal with a UK company, $19.5 million shares placed at a premium, 12 drug candidates, 3 layers of de-risking, an acquisition, & the Baxter relationship exceeding expectations.]]></description>
			<pubDate>Fri, 23 Sep 2011 09:27:00 +0100</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/ceo_focus/880/scott-maguire-ceo-of-xenetic-biosciences-talks-to-proactive-investors-880.html</guid>
		</item>
		<item>
			<title><![CDATA[Scott Maguire, CEO of Lipoxen, says it's a mystery why his company's share price is so low ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/stocktube/574/scott-maguire-ceo-of-lipoxen-says-its-a-mystery-why-his-companys-share-price-is-so-low-574.html</link>
			<description><![CDATA[Scott Maguire, CEO of Lipoxen, tells Proactive Investors why it's a mystery that his company's share price remains so low. He points to strengthened ties with US giant Baxter International plus positive results in trials for the company's influenza and flu treatments as reasons for a bright future.]]></description>
			<pubDate>Sun, 24 Oct 2010 10:33:00 +0100</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/stocktube/574/scott-maguire-ceo-of-lipoxen-says-its-a-mystery-why-his-companys-share-price-is-so-low-574.html</guid>
		</item>
		<item>
			<title><![CDATA[Lipoxen One2One Investor Presentation 15 October 2009 ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/ceo_focus/274/lipoxen-one2one-investor-presentation-15-october-2009-274.html</link>
			<description><![CDATA[Scott Maquire, CEO of Lipoxen, updates investors at the Proactive Investors One2One Forum on 15 October 2009]]></description>
			<pubDate>Thu, 15 Oct 2009 00:00:00 +0100</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/ceo_focus/274/lipoxen-one2one-investor-presentation-15-october-2009-274.html</guid>
		</item>
		<item>
			<title><![CDATA[Scott Maguire, CEO of Lipoxen, talks to proactiveinvestors ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/ceo_focus/364/scott-maguire-ceo-of-lipoxen-talks-to-proactiveinvestors-364.html</link>
			<description><![CDATA[]]></description>
			<pubDate>Mon, 24 Aug 2009 00:00:00 +0100</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/ceo_focus/364/scott-maguire-ceo-of-lipoxen-talks-to-proactiveinvestors-364.html</guid>
		</item>
</channel>
</rss>

